{"effective_time":"20171206","id":"8ee6fc5a-00e9-4bc7-b688-64c1be7cbc4f","openfda":{},"package_label_principal_display_panel":["Principal Display Panel NDC 0173-0750-49 Treximet ® (sumatriptan and naproxen sodium) Tablets 85 mg/500 mg R x only Do not repackage; dispense and store in original container. 9 Tablets Visit Treximet.com Federal Law requires the dispensing of TREXIMET®Tablets with the attached Medication Guide. Do not use if printed safety seal is broken or missing. Each tablet contains 85 mg of sumatriptan and 500 mg of naproxen sodium. See Prescribing Information for complete dosage information. Do not split, crush, or chew tablets. Store at 25°C (77°F); [see USP]. GlaxoSmithKline RTP, NC 27709 Made in UK Rev. 6/12 ©2012 GlaxoSmithKline 10000000105242 Treximet 9 count label"],"set_id":"d2329b4d-1359-4d8c-b58d-d7e7ceceb3bb","spl_product_data_elements":["TREXIMET sumatriptan and naproxen sodium SUMATRIPTAN SUCCINATE SUMATRIPTAN NAPROXEN SODIUM NAPROXEN CROSCARMELLOSE SODIUM DEXTROSE MONOHYDRATE ANHYDROUS DIBASIC CALCIUM PHOSPHATE FD&C BLUE NO. 2 LECITHIN, SOYBEAN MAGNESIUM STEARATE MALTODEXTRIN MICROCRYSTALLINE CELLULOSE POVIDONE, UNSPECIFIED SODIUM BICARBONATE CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM TALC TITANIUM DIOXIDE capsule-shaped TREXIMET"],"version":"3"}